Literature DB >> 22542978

Rapid affinity measurement of protein-protein interactions in a microfluidic platform.

Hossein Salimi-Moosavi1, Palaniswami Rathanaswami, Surendran Rajendran, Mike Toupikov, John Hill.   

Abstract

A rapid screening method has been developed to determine binding affinities for protein-ligand interactions using the Gyrolab workstation, a commercial microfluidic platform developed to accurately and precisely quantify proteins in solution. This method was particularly suited for assessing the high-affinity interactions that have become typical of therapeutic antibody-antigen systems. Five different commercially available antibodies that bind digoxin and a digoxin-bovine serum albumin (BSA) conjugate with high affinity were rigorously evaluated by this method and by the more conventional kinetic exclusion assay (KinExA) method. Binding parameter values obtained using Gyrolab were similar to those recovered from KinExA. However, the total experimental time for 20 binding affinity titrations, with each titration covering 12 data points in duplicate, took approximately 4h by the Gyrolab method, which reduced the experimental duration by more than 10-fold when compared with the KinExA method. This rapid binding analysis method has significant applications in the screening and affinity ranking selection of antibodies from a very large pool of candidates spanning a wide range of binding affinities from the low pM to μM range.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22542978     DOI: 10.1016/j.ab.2012.04.023

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  8 in total

1.  Affinity determination of biomolecules: a kinetic model for the analysis of pre-equilibrium titration curves.

Authors:  Emilie Vanhove; Marc Vanhove
Journal:  Eur Biophys J       Date:  2018-07-10       Impact factor: 1.733

2.  Development and validation of a cell-based fluorescent method for measuring antibody affinity.

Authors:  Xin Yu; Charles N Pegram; Darell D Bigner; Vidyalakshmi Chandramohan
Journal:  J Immunol Methods       Date:  2016-12-24       Impact factor: 2.303

3.  Smart surface for elution of protein-protein bound particles: nanonewton dielectrophoretic forces using atomic layer deposited oxides.

Authors:  Sam Emaminejad; Mehdi Javanmard; Robert W Dutton; Ronald W Davis
Journal:  Anal Chem       Date:  2012-12-06       Impact factor: 6.986

4.  IκBβ enhances the generation of the low-affinity NFκB/RelA homodimer.

Authors:  Rachel Tsui; Jeffrey D Kearns; Candace Lynch; Don Vu; Kim A Ngo; Soumen Basak; Gourisankar Ghosh; Alexander Hoffmann
Journal:  Nat Commun       Date:  2015-05-07       Impact factor: 14.919

Review 5.  Emerging Technologies and Generic Assays for the Detection of Anti-Drug Antibodies.

Authors:  Michael A Partridge; Shobha Purushothama; Chinnasamy Elango; Yanmei Lu
Journal:  J Immunol Res       Date:  2016-07-31       Impact factor: 4.818

6.  Computational modeling of microfluidic data provides high-throughput affinity estimates for monoclonal antibodies.

Authors:  Sonia Budroni; Francesca Buricchi; Andrea Cavallone; Gianfranco Volpini; Alessandra Mariani; Paola Lo Surdo; Christoph J Blohmke; Giuseppe Del Giudice; Duccio Medini; Oretta Finco
Journal:  Comput Struct Biotechnol J       Date:  2021-06-17       Impact factor: 7.271

7.  High throughput solution-based measurement of antibody-antigen affinity and epitope binning.

Authors:  Patricia Estep; Felicia Reid; Claire Nauman; Yuqi Liu; Tingwan Sun; Joanne Sun; Yingda Xu
Journal:  MAbs       Date:  2013 Mar-Apr       Impact factor: 5.857

Review 8.  Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity.

Authors:  Maurizio Benucci; Valentina Grossi; Mariangela Manfredi; Arianna Damiani; Maria Infantino; Paolo Moscato; Luigi Cinquanta; Elisa Gremese; Barbara Tolusso; Luca Petricca; Anna Laura Fedele; Stefano Alivernini; Fabiola Atzeni; Giovanni Minisola; Roberto Verna
Journal:  Ann Lab Med       Date:  2020-03       Impact factor: 3.464

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.